These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12128245)

  • 1. Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment.
    Soutullo CA; DelBello MP; Ochsner JE; McElroy SL; Taylor SA; Strakowski SM; Keck PE
    J Affect Disord; 2002 Aug; 70(3):323-7. PubMed ID: 12128245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence of Stimulant and Antidepressant Use by Australian Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: A National Survey.
    Sawyer MG; Reece CE; Sawyer AC; Johnson S; Lawrence D; Zubrick SR
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):177-184. PubMed ID: 27154239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset.
    DelBello MP; Soutullo CA; Hendricks W; Niemeier RT; McElroy SL; Strakowski SM
    Bipolar Disord; 2001 Apr; 3(2):53-7. PubMed ID: 11333062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats.
    Garland EJ
    J Psychopharmacol; 1998; 12(4):385-95. PubMed ID: 10065914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled study of switching from attention-deficit/hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6-year prospective follow-up: rate, risk, and predictors.
    Tillman R; Geller B
    Dev Psychopathol; 2006; 18(4):1037-53. PubMed ID: 17064428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
    Zeni CP; Tramontina S; Ketzer CR; Pheula GF; Rohde LA
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):553-61. PubMed ID: 19877980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant exposure in bipolar children.
    Cicero D; El-Mallakh RS; Holman J; Robertson J
    Psychiatry; 2003; 66(4):317-22. PubMed ID: 14964693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorder.
    Pagano ME; Demeter CA; Faber JE; Calabrese JR; Findling RL
    Bipolar Disord; 2008 Mar; 10(2):334-41. PubMed ID: 18271913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
    Bond DJ; Hadjipavlou G; Lam RW; McIntyre RS; Beaulieu S; Schaffer A; Weiss M;
    Ann Clin Psychiatry; 2012 Feb; 24(1):23-37. PubMed ID: 22303520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.
    Perugi G; Vannucchi G
    Expert Opin Pharmacother; 2015; 16(14):2193-204. PubMed ID: 26364896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipolar disorder and ADHD: comorbidity and diagnostic distinctions.
    Marangoni C; De Chiara L; Faedda GL
    Curr Psychiatry Rep; 2015 Aug; 17(8):604. PubMed ID: 26084666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.
    Biederman J; Seidman LJ; Petty CR; Fried R; Doyle AE; Cohen DR; Kenealy DC; Faraone SV
    J Clin Psychiatry; 2008 Jul; 69(7):1150-6. PubMed ID: 18517288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Palli SR; Kamble PS; Chen H; Aparasu RR
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BPD and ADHD.
    Lombardo GT
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):719-20. PubMed ID: 9183120
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental pathways for different subtypes of early-onset bipolarity in youths.
    Masi G; Mucci M; Pfanner C; Berloffa S; Magazù A; Perugi G
    J Clin Psychiatry; 2012 Oct; 73(10):1335-41. PubMed ID: 23058936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between attention deficit hyperactivity disorder, bipolarity and mixed features in major depressive patients: Evidence from the BRIDGE-II-Mix Study.
    Vannucchi G; Medda P; Pallucchini A; Bertelli M; Angst J; Azorin JM; Bowden C; Vieta E; Young AH; Mosolov S; Perugi G;
    J Affect Disord; 2019 Mar; 246():346-354. PubMed ID: 30597295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.